Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...

Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...

The potential to transform the lives of patients is what drives us at Biogen. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.

Since 2004 Biogen International has worked with health authorities, regulatory bodies, health care professionals and patient organizations to benefit people living with serious neurological and neurodegenerative diseases.

Mar 23, 2015 · The company has introduced a new corporate identity and logo that reflect both its evolution and focus on bringing forth new therapies in areas of high unmet need – while honoring Biogen’s scientific heritage and legacy as a pioneer in the biotechnology industry.

Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities.

Sep 29, 2023 · Developed by Bio-Thera, TOFIDENCE will be commercialized by Biogen in the United States. Under the agreement, Biogen has exclusive regulatory, manufacturing, and commercial rights to TOFIDENCE in all countries excluding …

Reata Pharmaceuticals has been acquired by Biogen. Disease Areas. Alzheimer's Disease; Amyotrophic Lateral Sclerosis; Friedreich Ataxia ; Kidney Disease; Lupus; Multiple Sclerosis; Postpartum Depression; Spinal Muscular Atrophy; Living with Alzheimer’s disease: Barry’s story Science & Innovation.

Apr 8, 2025 · Life at Biogen. How We Hire. Career Categories; Students & Graduates. Talent Community; Investors; News; Medicines Biogen. Medicines. Our medicines aim to improve the well-being of people around the world. Our Products. Below is a list of our company's therapies. The below information is intended for U.S. residents only.